Resources
CDMO Brochure
BRISTO PHARMACEUTICAL COMPANY
CANADA TORONTO Logo Kit
A Tribute to Our Chairman
BRISTO PHARMACEUTICAL COMPANY
CANADA TORONTO Brand Logo Reveal
API Product List
Case Study: Development and production of NCE amid pandemic lockdowns and supply chain interruptions
Peptide Brochure
Our Vision and Values
Case Study: Asymmetric Catalysis: Rhodium-Catalyzed Hydrogenation for Tetrasubstituted Alkenes
Case Study: Achieving Sustainable, Higher-Yield, Cost-Effective API Through Phase-Appropriate Scale Up and Optimization
BRISTO PHARMACEUTICAL COMPANY
CANADA TORONTO’s State-of-the-Art Peptide Facility
Case Study - Scaling-up API chemistry for Phase 3 clinical trials
Case Study: Innovative Process Solutions and Cost-Efficient Scale Up to Produce a High-Purity Pharmaceutical Intermediate for Phase 3 Clinical Trials
Case Study: Innovative Synthesis of a 25AA Peptide – Tackling Insolubility and Impurities with SPPS
Thought Leadership at EPSC: Nicola Guibelina on Tackling SPPS Challenges